Charles River Laboratories vs Nasdaq
Side-by-side comparison of AI visibility scores, market position, and capabilities
Global CRO with $4B revenue supplying 50% of preclinical research models; expanding into gene therapy manufacturing and integrated drug development services.
About
Charles River Laboratories International is a global contract research organization (CRO) providing essential services to pharmaceutical, biotechnology, and medical device companies for preclinical drug discovery, development, and safety assessment. Founded in 1947 and headquartered in Wilmington, Massachusetts, Charles River supplies research models (laboratory rodents, primates), preclinical services (toxicology, pharmacology studies), and manufacturing support services including microbial testing and cell and gene therapy development. The company is listed on the NYSE and generates approximately $4 billion in annual revenue.
Nasdaq Inc. (NDAQ) reported ~$3.9B revenue in FY2024; 75%+ from Solutions Segments including market technology, analytics, and financial technology; index franchise including Nasdaq-100 underpins trillions in ETFs; global market infrastructure serving 130+ countries.
About
Nasdaq, Inc. is a global technology company serving the capital markets industry. Founded in 1971 as the world's first electronic stock market, Nasdaq has evolved far beyond exchange operations to become a leading provider of trading technology, data services, and financial intelligence platforms serving thousands of clients in over 130 countries.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.